Technology
Health
Medical

Ra Medical

$4.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (5.26%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Ra Medical and other stocks, options, ETFs, and crypto commission-free!

About

Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Read More It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.

Employees
118
Headquarters
Carlsbad, California
Founded
2002
Market Cap
61.62M
Price-Earnings Ratio
Dividend Yield
Average Volume
119.86K
High Today
$4.98
Low Today
$4.30
Open Price
$4.30
Volume
86.37K
52 Week High
$22.00
52 Week Low
$3.34

Collections

Technology
Health
Medical
2018 IPO
US
North America

News

Seeking AlphaMay 17

Ra Medical sues Strata Skin Sciences for false statements in connection with IPO

Ra Medical Systems (NYSE:RMED) has filed a complaint in U.S. District Court for the Southern District of California alleging Mr. Uri Geiger, Chairman of Strata Skin Sciences (NASDAQ:SSKN) undertook a campaign of false, misleading and disparaging statements to Ra Medical’s financial partners and potential investors with respect to its IPO. Ra Medical desires a declaration that Strata breached the settlement agreement and committed trade libel. The Company is seeking monetary damages and such further relief ...

7
Seeking AlphaMay 13

Ra Medical Systems' CEO Dean Irwin on Q1 2019 Results - Earnings Call Transcript

Ra Medical Systems, Inc. (NYSE:RMED) Q1 2019 Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants Kevin McCabe – LHA Investor Relations Dean Irwin – Chief Executive Officer Tom Fogarty – Chief Commercial Officer Andrew Jackson – Chief Financial Officer Conference Call Participants Matthew O’Brien – Piper Jaffray Bruce Nudell – SunTrust Craig Bijou – Cantor Fitzgerald Anthony Vendetti – Maxim Group Operator Ladies and gentlemen, thank you for standing by. Welcome to the Ra Medica...

17
Yahoo FinanceMay 13

Ra Medical Systems Reports First Quarter 2019 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)-- Submits IDE for atherectomy clinical trial with DABRA excimer laser system Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three months ended March 31, 2019 and provides a business update. This press release features multimedia. View the full release here: https://www.busines...

14

Earnings

-$1.18
-$0.90
-$0.63
-$0.35
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.38 per share
Actual
-$1.16 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.